{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:00:03Z","timestamp":1790283603123,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Hyperkalemia is a common electrolyte disturbance in both inpatient and outpatient clinical practice. The severity and associated risk depends on the underlying cause and rate of potassium (K+) increase. Acute hyperkalemia requires immediate attention due to potentially life-threatening manifestations resulting from the rapid increase in plasma K+ concentration. Treatment is initially focused on stabilizing the cardiac membrane, followed by maneuvers to shift K+ into the cells, and ultimately initiating strategies to decrease total body K+ content. Chronic hyperkalemia develops over a more extended period of time and manifestations tend to be less severe. Nevertheless, the disorder is not benign since chronic hyperkalemia is associated with increased morbidity and mortality. The approach to patients with chronic hyperkalemia begins with a review of medications potentially responsible for the disorder, ensuring effective diuretic therapy and correcting metabolic acidosis if present. The practice of restricting foods high in K+ to manage hyperkalemia is being reassessed since the evidence supporting the effectiveness of this strategy is lacking. Rather, dietary restriction should be more nuanced, focusing on reducing the intake of nonplant sources of K+. Down-titration and\/or discontinuation of renin\u2013angiotensin\u2013aldosterone inhibitors should be discouraged since these drugs improve outcomes in patients with heart failure and proteinuric kidney disease. In addition to other conservative measures, K+ binding drugs and sodium\u2013glucose cotransporter 2 inhibitors can assist in maintaining the use of these drugs.<\/jats:p>","DOI":"10.1093\/ndt\/gfae056","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T06:54:18Z","timestamp":1709103258000},"page":"1097-1104","source":"Crossref","is-referenced-by-count":38,"title":["Hyperkalemia treatment standard"],"prefix":"10.1093","volume":"39","author":[{"given":"Biff F","family":"Palmer","sequence":"first","affiliation":[{"name":"Professor of Internal Medicine, Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center , Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J","family":"Clegg","sequence":"additional","affiliation":[{"name":"Professor of Internal Medicine, Vice President for Research, Texas Tech Health Sciences Center, El Paso , TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"2024062723554367200_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib2","volume-title":"Clinical practice guidelines: treatment of acute hyperkalaemia in adults","author":"Alfonzo","year":"2020"},{"key":"2024062723554367200_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jash.2017.09.011","article-title":"Potassium homeostasis in health and disease: a scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension","volume":"11","author":"Kovesdy","year":"2017","journal-title":"J Am Soc Hypertens"},{"key":"2024062723554367200_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.01150112","article-title":"Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic","volume":"7","author":"Sarafidis","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024062723554367200_bib5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ekir.2021.02.038","article-title":"Hyperkalemia and its association with mortality, cardiovascular events, hospitalizations, and intensive care unit admissions in a population-based retrospective cohort","volume":"6","author":"Hougen","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2024062723554367200_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"key":"2024062723554367200_bib7","doi-asserted-by":"crossref","first-page":"e004667","DOI":"10.1161\/CIRCEP.116.004667","article-title":"Electrophysiology of hypokalemia and hyperkalemia","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024062723554367200_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2215\/CJN.04611007","article-title":"Retrospective review of the frequency of ECG changes in hyperkalemia","volume":"3","author":"Montague","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024062723554367200_bib9","first-page":"697","article-title":"Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: a prospective, dose-response study","volume":"22","author":"Bisogno","year":"1994","journal-title":"Crit Care Med"},{"key":"2024062723554367200_bib10","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.96.7.4158","article-title":"Distinguishing surface effects of calcium ion from pore-occupancy effects in Na+ channels","volume":"96","author":"Armstrong","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024062723554367200_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib12","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches","volume":"74","author":"Ngugi","year":"1997","journal-title":"East Afr Med J"},{"key":"2024062723554367200_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/08860229309065576","article-title":"Should glucose be administered before, with, or after insulin, in the management of hyperkalemia?","volume":"15","author":"Ljuti\u0107","year":"1993","journal-title":"Ren Fail"},{"key":"2024062723554367200_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-110-6-426","article-title":"Nebulized albuterol for acute hyperkalemia in patients on hemodialysis","volume":"110","author":"Allon","year":"1989","journal-title":"Ann Intern Med"},{"key":"2024062723554367200_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.ndt.a091860","article-title":"Treatment of hyperkalaemia in renal failure: salbutamol v. insulin","volume":"4","author":"Lens","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"2024062723554367200_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ki.1992.51","article-title":"Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure","volume":"41","author":"Blumberg","year":"1992","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamainternmed.2019.0631","article-title":"Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age","volume":"179","author":"Noel","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2024062723554367200_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"2024062723554367200_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfu376","article-title":"Ranking of factors determining potassium mass balance in bicarbonate haemodialysis","volume":"30","author":"Basile","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2024062723554367200_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1525-139x.2001.00013.x","article-title":"Individualizing the dialysate in the hemodialysis patient","volume":"14","author":"Palmer","year":"2001","journal-title":"Semin Dial"},{"key":"2024062723554367200_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","article-title":"Clinical management of hyperkalemia","volume":"96","author":"Palmer","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2024062723554367200_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ki.1977.66","article-title":"Potassium homeostasis in renal failure","volume":"11","author":"van Y persele de Strihou","year":"1977","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib24","first-page":"R989","article-title":"Renal potassium transport: morphological and functional adaptations","volume":"257","author":"Stanton","year":"1989","journal-title":"Am J Physiol"},{"key":"2024062723554367200_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.1750","article-title":"Enhanced large intestinal potassium permeability in end-stage renal disease","volume":"206","author":"Mathialahan","year":"2005","journal-title":"J Pathol"},{"key":"2024062723554367200_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.ajkd.2019.03.427","article-title":"Physiology and pathophysiology of potassium homeostasis: core curriculum 2019","volume":"74","author":"Palmer","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2024062723554367200_bib27","first-page":"516","article-title":"Renal complications associated with use of nonsteroidal anti-inflammatory agents","volume":"43","author":"Palmer","year":"1995","journal-title":"J Investig Med"},{"key":"2024062723554367200_bib28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.1991.321","article-title":"Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease","volume":"40","author":"Allon","year":"1991","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMra035279","article-title":"Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system","volume":"351","author":"Palmer","year":"2004","journal-title":"N Engl J Med"},{"key":"2024062723554367200_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mayocp.2019.05.019","article-title":"Potassium binders for hyperkalemia in chronic kidney disease\u2014diet, renin-angiotensin-aldosterone system inhibitor therapy, and hemodialysis","volume":"95","author":"Palmer","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2024062723554367200_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.34067\/KID.0000222019","article-title":"Potassium homeostasis, chronic kidney disease, and the plant-enriched diets","volume":"1","author":"Palmer","year":"2020","journal-title":"Kidney360"},{"key":"2024062723554367200_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/nu16010003","article-title":"Re-thinking hyperkalaemia management in chronic kidney disease-beyond food tables and nutrition myths: an evidence-based practice review","volume":"16","author":"MacLaughlin","year":"2023","journal-title":"Nutrients"},{"issue":"6 Suppl","key":"2024062723554367200_bib33","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1053\/j.jrn.2022.12.003","article-title":"New insights into dietary approaches to potassium management in chronic kidney disease","volume":"33","author":"Sumida","year":"2023","journal-title":"J Ren Nutr"},{"key":"2024062723554367200_bib34","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for hypertension in advanced chronic kidney disease","volume":"385","author":"Agarwal","year":"2021","journal-title":"N Engl J Med"},{"key":"2024062723554367200_bib35","first-page":"S73","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"11 Suppl","key":"2024062723554367200_bib36","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"2024062723554367200_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2022.01.002","article-title":"Hyperkalemia-related discontinuation of renin-angiotensin-aldosterone system inhibitors and clinical outcomes in CKD: a population-based cohort study","volume":"80","author":"Leon","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024062723554367200_bib38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/ejhf.2612","article-title":"An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum","volume":"24","author":"Burton","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2024062723554367200_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"2024062723554367200_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4 Suppl","key":"2024062723554367200_bib41","first-page":"S1","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"Kidney Disease: Improving Global Outcomes Diabetes Work Group","year":"2020","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Kidney Disease: Improving Global Outcomes Blood Pressure Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2024062723554367200_bib43","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024062723554367200_bib44","doi-asserted-by":"crossref","first-page":"106277","DOI":"10.1016\/j.phrs.2022.106277","article-title":"Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease","volume":"182","author":"Rossignol","year":"2022","journal-title":"Pharmacol Res"},{"key":"2024062723554367200_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2215\/CJN.0000000000000300","article-title":"SGLT2 inhibition and kidney potassium homeostasis","volume":"19","author":"Palmer","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024062723554367200_bib46","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/CIRCULATIONAHA.121.057736","article-title":"Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials","volume":"145","author":"Neuen","year":"2022","journal-title":"Circulation"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfae056\/56998921\/gfae056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/7\/1097\/58346657\/gfae056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/7\/1097\/58346657\/gfae056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:58:19Z","timestamp":1719532699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/39\/7\/1097\/7616929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,2,29]]},"published-print":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfae056","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,2,29]]}}}